Position in ZTS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$4,286,449
+$519,097 QoQ
Shares Held
59,650
+87.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#365
of 1,412 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ASR Vermogensbeheer N.V. holds $48,081,797 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
1,241,434 | $30,551,690 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
19,047 | $10,320,236 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
59,650 | $4,286,449 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
57,395 | $1,944,542 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
5,808 | $978,880 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,286,449 | 59,650 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $3,767,352 | 31,870 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $3,894,380 | 30,952 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $4,559,477 | 31,161 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $4,857,062 | 31,145 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $5,110,077 | 31,036 | Shares | Defined | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||